Sustainability framework

Our sustainability framework:

As a company built on delivering positive health outcomes, sustainability underpins everything we do. As we strive to reach more and more patients by 2025, we are evolving our approach and developing a roadmap that will further embed sustainability into our DNA. This will ensure we effectively address the most fundamental issues for our business and for society. Our sustainability framework demonstrates our commitment to operating responsibly, working with integrity and delivering sustainable growth. In 2015, the DU Laboratories Limited Board endorsed an initiative to pursue a clear and prioritised sustainability framework that is closely aligned to the company’s overall business strategy.

Our sustainability priorities were initially set in 2013. In late 2015, we initiated a refreshed materiality assessment that includes input from internal and external stakeholders. We are using the assessment to refine our priorities further and confirm our strategy, as we develop a roadmap towards further embedding sustainability into the DNA of our company.

Five pillars of sustainability:

  1. Access to healthcare - Increasing access to healthcare for underserved patient populations in a sustainable way.
  2. Environmental sustainability - Managing our environmental impacts with a focus on:
    • Carbon emissions
    • Waste
    • Water use
    • Product stewardship
  3. Great place to work - Building an inclusive, safe and trusting organisation that embraces the skills, knowledge and unique ability of our employees. Supporting them to make a positive contribution to local communities.
  4. Responsible research - Underpinning innovation with sound bioethics worldwide. Maintaining a strong focus on patient safety.Taking responsibility for our medicines throughout research and development, and after launch.
  5. Ethical business practices - Delivering globally consistent standards of ethical sales and marketing. Working only with suppliers who have standards consistent with our own.Taking a responsible and fair approach to tax.

Stakeholder engagement

We believe our long-term success lies in making better, deeper connections with our stakeholders, understanding their worlds and combining forces to achieve common goals. To earn society’s trust, we must speak but also listen. The feedback we receive from stakeholders, through both the materiality process and ongoing stakeholder dialogue, informs our sustainability approach, commitments and actions. We define a stakeholder as any individual or group who can affect, or is affected by, our business.

The benefits of dialogue with our stakeholders include:
  • Better healthcare solutions - deeper stakeholder relationships will help us come up with creative ways to tackle healthcare challenges.
  • Better informed stakeholders - information presented as part of a dialogue is more easily digested and understood, helping stakeholders to understand our business Examples of our stakeholders - Our stakeholders include diverse groups with wide-ranging interests, from the patients who use our medicines to the academic institutions that collaborate with our scientists and the communities in which we operate.
  • Better decision-making - listening to stakeholders will improve our knowledge of present and future threats and opportunities, helping us to make good business decisions.
  • Better reputation - responding appropriately to the changing expectations and concerns of our stakeholders will strengthen our reputation.

How we engage with stakeholders

We carry out regular formal and informal engagement with stakeholders through a wide range of channels – from digital to face-to-face dialogue – to understand their views and concerns. Through a multi-stakeholder engagement approach, we identify systematic activities to create opportunities for interaction with groups of our stakeholders. We continue to use feedback from our various stakeholder dialogues to make sure that appropriate considerations are being included in our strategy development and risk management planning. All our relationships and engagement, including with patient groups and other healthcare organisations, are based on transparent and shared objectives to improve the lives of patients.

Our work with patient groups

Patient groups are independent organisations that provide advice and support to patients and their families and other caregivers. Staying in touch with their changing needs is vital to our aim of making the most meaningful difference we can to patient health. We continually talk to patient groups, organisations and physicians to understand what they need and want.

Responsible partnering

We partner with other organisations to promote access to the best science, and to stimulate innovation for the delivery of new, life-changing medicines. We are always looking for business development opportunities that support our vision and help deliver our business strategy.

Our current focus is on:
  • Increasing early-stage research and academic partnerships.
  • Exploring opportunities to create value for society with our peers.
  • Pursuing partnering, in-licensing and bolt-on acquisitions to strengthen our core therapy area portfolios.

Ensuring these partnerships are transparent and uphold our high ethical standards is vital to our reputation. When making new acquisitions and developing partnership opportunities, sustainability is integral to our due diligence process.

We assess all projects against our 5Rs evaluation criteria:
  1. Right Target,
  2. Right Tissue or Exposure,
  3. Right Safety,
  4. Right Patients and
  5. Right Commercial.

We also consider ethical conduct in sales and marketing, safety, environmental management and other sustainability issues – including the historical liabilities of potential partners and the practices they currently have in place. This way, we ensure that we only take forward the most attractive and sustainable opportunities.